References
- Sung H , FerlayJ, SiegelRLet al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin.71(3), 209–249 (2021).
- Pennathur A , GibsonMK, JobeBA, LuketichJD. Oesophageal carcinoma. Lancet381(9864), 400–412 (2013).
- Bagaria B , SoodS, SharmaR,LalwaniS. Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis). Cancer Biol Med.10(3), 148–157 (2013).
- Plantureux L , MegeD, CrescenceL, Dignat-GeorgeF, DuboisC, Panicot-DuboisL. Impacts of cancer on platelet production, activation and education and mechanisms of cancer-associated thrombosis. Cancers (Basel)10(11), 441 (2018).
- Best MG , WesselingP, WurdingerT. Tumor-educated platelets as a noninvasive biomarker source for cancer detection and progression monitoring. Cancer Res.78(13), 3407–3412 (2018).
- Nilsson RJ , BalajL, HullemanEet al. Blood platelets contain tumor-derived RNA biomarkers. Blood118(13), 3680–3683 (2011).
- Mendoza-Almanza G , Burciaga-HernandezL, MaldonadoV, Melendez-ZajglaJ, OlmosJ. Role of platelets and breast cancer stem cells in metastasis. World J. Stem Cells12(11), 1237–1254 (2020).
- In’T Veld S , WurdingerT. Tumor-educated platelets. Blood133(22), 2359–2364 (2019).
- Best MG , SolN, In’TVeld Set al. Swarm intelligence-enhanced detection of non-small-cell lung cancer using tumor-educated platelets. Cancer Cell32(2), 238–252; e239 (2017).
- Best MG , SolN, KooiIet al. RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell28(5), 666–676 (2015).
- Xiao R , LiuC, ZhangB, MaL. Tumor-educated platelets as a promising biomarker for blood-based detection of renal cell carcinoma. Front. Oncol.12, 844520 (2022).
- Shen Y , LaiY, XuDet al. Diagnosis of thyroid neoplasm using support vector machine algorithms based on platelet RNA-seq. Endocrine72(3), 758–783 (2021).
- Pastuszak K , SupernatA, BestMGet al. imPlatelet classifier: image-converted RNA biomarker profiles enable blood-based cancer diagnostics. Mol. Oncol.15(10), 2688–2701 (2021).
- Heinhuis KM , In’TVeld S, DwarshuisGet al. RNA-sequencing of tumor-educated platelets, a novel biomarker for blood-based sarcoma diagnostics. Cancers (Basel)12(6), 1372 (2020).
- Sol N , In’TVeld S, VancuraAet al. Tumor-educated platelet RNA for the detection and (pseudo) progression monitoring of glioblastoma. Cell Rep. Med.1(7), 100101 (2020).
- Kiss T . Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell109(2), 145–148 (2002).
- Yoshida K , TodenS, WengWet al. SNORA21 – an oncogenic small nucleolar RNA, with a prognostic biomarker potential in human colorectal cancer. EBioMedicine22, 68–77 (2017).
- Shan Y , WeiS, XiangXet al. SNORA42 promotes oesophageal squamous cell carcinoma development through triggering the DHX9/p65 axis. Genomics113(5), 3015–3029 (2021).
- Kishore S , KhannaA, ZhangZet al. The snoRNA MBII-52 (SNORD115) is processed into smaller RNAs and regulates alternative splicing. Hum. Mol. Genet.19(7), 1153–1164 (2010).
- Bray PF , MckenzieSE, EdelsteinLCet al. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics14, 1 (2013).
- Best MG , VancuraA, WurdingerT. Platelet RNA as a circulating biomarker trove for cancer diagnostics. J. Thromb. Haemost.15(7), 1295–1306 (2017).
- Amin MB , GreeneFL, EdgeSBet al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more ‘personalized’ approach to cancer staging. CA Cancer J Clin.67(2), 93–99 (2017).
- Bullard JH , PurdomE, HansenKD, DudoitS. Evaluation of statistical methods for normalization and differential expression in mRNA-seq experiments. BMC Bioinformatics11, 94 (2010).
- Ko HH , LeeJJ, ChenHMet al. Upregulation of vascular endothelial growth factor mRNA level is significantly related to progression and prognosis of oral squamous cell carcinomas. J. Formos. Med. Assoc.114(7), 605–611 (2015).
- Liang J , WenJ, HuangZ, ChenXP, ZhangBX, ChuL. Small nucleolar RNAs: insight into their function in cancer. Front. Oncol.9, 587 (2019).
- Kishore S , StammS. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science311(5758), 230–232 (2006).
- Falaleeva M , PagesA, MatuszekZet al. Dual function of C/D box small nucleolar RNAs in rRNA modification and alternative pre-mRNA splicing. Proc. Natl Acad. Sci. USA113(12), E1625–E1634 (2016).
- Huang C , ShiJ, GuoYet al. A snoRNA modulates mRNA 3′ end processing and regulates the expression of a subset of mRNAs. Nucleic Acids Res.45(15), 8647–8660 (2017).
- Zhong F , ZhouN, WuKet al. A snoRNA-derived piRNA interacts with human interleukin-4 pre-mRNA and induces its decay in nuclear exosomes. Nucleic Acids Res.43(21), 10474–10491 (2015).
- Lee J , HarrisAN, HolleyCLet al. Rpl13a small nucleolar RNAs regulate systemic glucose metabolism. J. Clin. Invest.126(12), 4616–4625 (2016).
- Michel CI , HolleyCL, ScruggsBSet al. Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab.14(1), 33–44 (2011).
- Sonohara F , GaoF, IwataNet al. Genome-wide discovery of a novel gene-expression signature for the identification of lymph node metastasis in esophageal squamous cell carcinoma. Ann. Surg.269(5), 879–886 (2019).
- Oliveira D , PrahmKP, ChristensenIJ, HansenA, HogdallCK, HogdallEV. Noncoding RNA (ncRNA) profile association with patient outcome in epithelial ovarian cancer cases. Reprod. Sci.28(3), 757–765 (2021).
- Zhao Y , YanY, MaRet al. Expression signature of six-snoRNA serves as novel non-invasive biomarker for diagnosis and prognosis prediction of renal clear cell carcinoma. J. Cell Mol. Med.24(3), 2215–2228 (2020).
- Patterson DG , RobertsJT, KingVMet al. Human snoRNA-93 is processed into a microRNA-like RNA that promotes breast cancer cell invasion. NPJ Breast Cancer3, 25 (2017).